Beijing Golden Tang Medicine Science & Technology Development

Beijing Golden Tang Medicine Science & Technology Development is a specialized pharmaceutical and research organization based in China, focusing on the modernization and clinical validation of Traditional Chinese Medicine (TCM). The company integrates drug R&D, clinical trial management (CRO), and technology transfer, with a primary focus on metabolic and cardiovascular diseases. Its internal pipeline is directed toward chronic conditions, with its most prominent product being Jin Tang Ning for the treatment of Type 2 diabetes. By applying modern pharmacological standards to herbal formulations, the company aims to provide evidence-based TCM therapies. Golden Tang Medicine also serves as a bridge for other pharmaceutical firms navigating the regulatory landscape for TCM in the Chinese market.